These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 34559314)
1. Efficacy of three lytic bacteriophages for eradicating biofilms of multidrug-resistant Proteus mirabilis. Esmael A; Abo-Elmaaty SA; Khafaga EM; Abdelrahman S; Hassan MG Arch Virol; 2021 Dec; 166(12):3311-3322. PubMed ID: 34559314 [TBL] [Abstract][Full Text] [Related]
2. Development of a Phage Cocktail to Control Proteus mirabilis Catheter-associated Urinary Tract Infections. Melo LD; Veiga P; Cerca N; Kropinski AM; Almeida C; Azeredo J; Sillankorva S Front Microbiol; 2016; 7():1024. PubMed ID: 27446059 [TBL] [Abstract][Full Text] [Related]
3. A Phage Cocktail To Control Surface Colonization by Proteus mirabilis in Catheter-Associated Urinary Tract Infections. Mirzaei A; Wagemans J; Nasr Esfahani B; Lavigne R; Moghim S Microbiol Spectr; 2022 Oct; 10(5):e0209222. PubMed ID: 36194151 [TBL] [Abstract][Full Text] [Related]
4. Isolation and Characterization of a Lytic Bacteriophage (vB_PmiS-TH) and Its Application in Combination with Ampicillin against Planktonic and Biofilm Forms of Proteus mirabilis Isolated from Urinary Tract Infection. Yazdi M; Bouzari M; Ghaemi EA J Mol Microbiol Biotechnol; 2018; 28(1):37-46. PubMed ID: 29617701 [TBL] [Abstract][Full Text] [Related]
5. Elimination of multidrug-resistant Proteus mirabilis biofilms using bacteriophages. Gomaa S; Serry F; Abdellatif H; Abbas H Arch Virol; 2019 Sep; 164(9):2265-2275. PubMed ID: 31197549 [TBL] [Abstract][Full Text] [Related]
6. Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections. Maszewska A; Zygmunt M; Grzejdziak I; Różalski A J Appl Microbiol; 2018 Nov; 125(5):1253-1265. PubMed ID: 29924909 [TBL] [Abstract][Full Text] [Related]
7. Characterization, genome analysis and antibiofilm efficacy of lytic Proteus phages RP6 and RP7 isolated from university hospital sewage. Ali S; Karaynir A; Salih H; Öncü S; Bozdoğan B Virus Res; 2023 Mar; 326():199049. PubMed ID: 36717023 [TBL] [Abstract][Full Text] [Related]
8. Phage P2-71 against multi-drug resistant Dong Z; Wu R; Liu L; Ai S; Yang J; Li Q; Fu K; Zhou Y; Fu H; Zhou Z; Liu H; Zhong Z; Qiu X; Peng G Front Cell Infect Microbiol; 2024; 14():1347173. PubMed ID: 38500503 [No Abstract] [Full Text] [Related]
9. Genomic analyses of a novel bacteriophage (VB_PmiS-Isfahan) within Siphoviridae family infecting Proteus mirabilis. Yazdi M; Bouzari M; Ghaemi EA Genomics; 2019 Dec; 111(6):1283-1291. PubMed ID: 30149052 [TBL] [Abstract][Full Text] [Related]
10. Isolation and Characterization of Lytic Aaron J; van Zyl LJ; Dicks LMT Viruses; 2022 Jun; 14(6):. PubMed ID: 35746779 [No Abstract] [Full Text] [Related]
11. Isolation, characterization and genomic analysis of vB-AhyM-AP1, a lytic bacteriophage infecting Aeromonas hydrophila. Pallavi B; Puneeth TG; Shekar M; Girisha SK J Appl Microbiol; 2021 Aug; 131(2):695-705. PubMed ID: 33420733 [TBL] [Abstract][Full Text] [Related]
12. Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India. Chaudhary N; Mohan B; Mavuduru RS; Kumar Y; Taneja N J Appl Microbiol; 2022 Apr; 132(4):3387-3404. PubMed ID: 34989075 [TBL] [Abstract][Full Text] [Related]
13. Characterization and comprehensive genome analysis of novel bacteriophage, vB_Kpn_ZCKp20p, with lytic and anti-biofilm potential against clinical multidrug-resistant Zaki BM; Fahmy NA; Aziz RK; Samir R; El-Shibiny A Front Cell Infect Microbiol; 2023; 13():1077995. PubMed ID: 36756618 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of polyvalent bacteriophages specific to uropathogenic Proteus mirabilis strains based on the host range pattern and RFLP. Maszewska A; Wójcik E; Ciurzyńska A; Wojtasik A; Piątkowska I; Dastych J; Różalski A Acta Biochim Pol; 2016; 63(2):303-10. PubMed ID: 26730411 [TBL] [Abstract][Full Text] [Related]
15. Characterization and Anti-Biofilm Activity of Lytic Enterococcus Phage vB_Efs8_KEN04 against Clinical Isolates of Multidrug-Resistant Soro O; Kigen C; Nyerere A; Gachoya M; Georges M; Odoyo E; Musila L Viruses; 2024 Aug; 16(8):. PubMed ID: 39205249 [No Abstract] [Full Text] [Related]
16. Genomic and Ecogenomic Characterization of Alves DR; Nzakizwanayo J; Dedi C; Olympiou C; Hanin A; Kot W; Hansen L; Lametsch R; Gahan CGM; Schellenberger P; Ogilvie LA; Jones BV Front Microbiol; 2019; 10():1783. PubMed ID: 31447809 [No Abstract] [Full Text] [Related]
17. Novel Phage-Derived Depolymerase with Activity against Rice CJ; Kelly SA; O'Brien SC; Melaugh EM; Ganacias JCB; Chai ZH; Gilmore BF; Skvortsov T Microorganisms; 2021 Oct; 9(10):. PubMed ID: 34683494 [TBL] [Abstract][Full Text] [Related]
18. Isolation, biological and whole genome characteristics of a Proteus mirabilis bacteriophage strain. Hao X; Cen X; He M; Wen Y; Zhang H BMC Microbiol; 2023 Aug; 23(1):215. PubMed ID: 37553593 [TBL] [Abstract][Full Text] [Related]
19. A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa. Abdelghafar A; El-Ganiny A; Shaker G; Askoura M Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1207-1234. PubMed ID: 37608144 [TBL] [Abstract][Full Text] [Related]
20. Phage JS02, a putative temperate phage, a novel biofilm-degrading agent for Staphylococcus aureus. Zhang L; Shahin K; Soleimani-Delfan A; Ding H; Wang H; Sun L; Wang R Lett Appl Microbiol; 2022 Sep; 75(3):643-654. PubMed ID: 35100443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]